Duke Cancer Institute gynecologic oncologist and Professor of Obstetrics and Gynecology Angeles Alvarez Secord, MD, MHSc, was officially installed as president of the Society of Gynecologic Oncology at the Society's Annual Meeting, held March 25-28, 2023.
“It is my privilege and honor to serve as the 55th president of SGO,” Secord said at the meeting. “The theme for our year is ‘The Power of Shared Purpose: Transforming Gynecologic Cancer Care.’”
Secord, who serves as associate director of clinical research in DCI's Gynecologic Cancer Disease Group, has been a member of the faculty since 2001. She's been member of DCI since 1994 when she first joined Duke as an OB-GYN resident after earning her MD at the University of Washington. From 1998 to 2001, she was a DCI GynOnc fellow. She was named a full professor in 2013.
Secord's research is centered on novel therapeutics, biomarkers, and clinical trial development for ovarian and endometrial cancer. A national leader in the field, her efforts contributed to the approval in 2017 of Niraparib, a PARP inhibitor, to treat ovarian cancer.
Secord already had a national profile prior to her election as SGO president. She has been an active member of SGO since 2001; serving initially on the SGO Fellow’s Task Force and later as chair of the Candidate’s Task Force. She was inspired to serve SGO further during her role as an ex-officio member on the SGO Council from 2003 to 2005 and, according to an article by SGO introducing her as its new president, "credits that experience for opening the door to future leadership possibilities."
Secord has participated on several SGO and Foundation for Women’s Cancer committees, task force initiatives and program committees. She serves as co-chair of Education and Mentoring at the GOG (Gynecologic Oncology Group) Foundation; chair of the Scholar Committee at the American Association of Obstetricians and Gynecologists Foundation; and vice chair of the New Investigator Committee at NRG Oncology. Secord is a fellow of the American College of Obstetricians and Gynecologists and an active member of American Society of Clinical Oncology, the American Gynecological & Obstetrical Society, and the International Gynecologic Cancer Society.